🇺🇸#premarket #сша
премаркет США - акции - заметные движения:
ВВЕРХ
#NAVB +65% Navidea Biopharmaceuticals, Inc. - reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
#TTPH +48% Tetraphase Pharmaceuticals, Inc. - announced determination of superior offer from Melinta Therapeutics, Inc.
#SNDL +26% Sundial Growers Inc. - after gaining over 9% on Thursday.
#NTEC +15% Intec Pharma Ltd. - after jumping 23% on Thursday.
#TTOO +15% T2 Biosystems, Inc.
#BLIN +13% Bridgeline Digital, Inc.
#DKL +9% Delek Logistics Partners, LP
#ENTX +8% Entera Bio Ltd. - shares tumbled 27% on Thursday as the company announced interim limited biomarker data from the ongoing Phase 2 clinical trial of EB613 in osteoporosis patients, with the study demonstrating statistically significant effects on the P1NP biomarker after one month of treatment as compared to placebo, and meaningful increases at months two and three as compared to placebo with the highest EB613 dose of 1.5mg.
#ONCY +7% Oncolytics Biotech Inc. -after declining 5% on Thursday.
#PAWN +7% Palo Alto Networks Inc - reported better-than-expected Q3 results. The company also issued FY20 guidance above estimates.
#CNAT +7% Conatus Pharmaceuticals Inc. -after declining 13% on Thursday.
#CLNS +7% Celsion Corporation -after jumping over 36% on Thursday.
#A +5% Agilent Technologies Inc - reported better-than-expected Q2 results.
#BKE +4% Buckle Inc - following Q1 results.
ВНИЗ
#SNDX -20% Syndax Pharmaceuticals, Inc. - reported receipt of final results from Phase 3 E2112 trial of entinostat plus exemestane in patients with HR+, HER2- breast cancer. The trial did not achieve primary endpoint.
#GERN -19% Geron Corporation - announced a proposed public offering of common stock and warrants..
#AKTX -15% Akari Therapeutics, Plc - on Thursday, Akari Therapeutics received positive EMA opinion on orphan designation for nomacopan for bullous pemphigoid.
#PDSB -14% PDS Biotechnology Corporation -after surging 17% on Thursday.
#SONM -13% Sonim Technologies, Inc. - after rising 15% on Thursday.
#XTNT -13% Xtant Medical Holdings, Inc. - after jumping 160% on Thursday.
#HOTH -13% Hoth Therapeutics, Inc. - priced underwritten public offering of 1.8 million shares at $2.75 per share.
#LSCC -12% Lattice Semiconductor Corporation
#CFRX -10% ContraFect Corp - announced a proposed public offering of common stock and warrants.
#IMAB -10% I-Mab - I-Mab and Genexine reported China NMPA clearance for Phase 2 clinical trial of TJ107/HyLeukin-7 in glioblastoma multiforme.
#MPWR -9% Monolithic Power Systems, Inc.
#MXL -9% MaxLinear, Inc. - after dropping over 6% on Thursday.
#DVAX -8% Dynavax Technologies Corporation - announced a proposed public offering of common stock.
#NNDM -6% Nano Dimension Ltd.
#HPE -5% Hewlett Packard Enterprise Co - reported weaker-than-expected Q2 results.
#GDS -5% GDS Holdings Limited - after declining over 5% on Thursday.
премаркет США - акции - заметные движения:
ВВЕРХ
#NAVB +65% Navidea Biopharmaceuticals, Inc. - reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
#TTPH +48% Tetraphase Pharmaceuticals, Inc. - announced determination of superior offer from Melinta Therapeutics, Inc.
#SNDL +26% Sundial Growers Inc. - after gaining over 9% on Thursday.
#NTEC +15% Intec Pharma Ltd. - after jumping 23% on Thursday.
#TTOO +15% T2 Biosystems, Inc.
#BLIN +13% Bridgeline Digital, Inc.
#DKL +9% Delek Logistics Partners, LP
#ENTX +8% Entera Bio Ltd. - shares tumbled 27% on Thursday as the company announced interim limited biomarker data from the ongoing Phase 2 clinical trial of EB613 in osteoporosis patients, with the study demonstrating statistically significant effects on the P1NP biomarker after one month of treatment as compared to placebo, and meaningful increases at months two and three as compared to placebo with the highest EB613 dose of 1.5mg.
#ONCY +7% Oncolytics Biotech Inc. -after declining 5% on Thursday.
#PAWN +7% Palo Alto Networks Inc - reported better-than-expected Q3 results. The company also issued FY20 guidance above estimates.
#CNAT +7% Conatus Pharmaceuticals Inc. -after declining 13% on Thursday.
#CLNS +7% Celsion Corporation -after jumping over 36% on Thursday.
#A +5% Agilent Technologies Inc - reported better-than-expected Q2 results.
#BKE +4% Buckle Inc - following Q1 results.
ВНИЗ
#SNDX -20% Syndax Pharmaceuticals, Inc. - reported receipt of final results from Phase 3 E2112 trial of entinostat plus exemestane in patients with HR+, HER2- breast cancer. The trial did not achieve primary endpoint.
#GERN -19% Geron Corporation - announced a proposed public offering of common stock and warrants..
#AKTX -15% Akari Therapeutics, Plc - on Thursday, Akari Therapeutics received positive EMA opinion on orphan designation for nomacopan for bullous pemphigoid.
#PDSB -14% PDS Biotechnology Corporation -after surging 17% on Thursday.
#SONM -13% Sonim Technologies, Inc. - after rising 15% on Thursday.
#XTNT -13% Xtant Medical Holdings, Inc. - after jumping 160% on Thursday.
#HOTH -13% Hoth Therapeutics, Inc. - priced underwritten public offering of 1.8 million shares at $2.75 per share.
#LSCC -12% Lattice Semiconductor Corporation
#CFRX -10% ContraFect Corp - announced a proposed public offering of common stock and warrants.
#IMAB -10% I-Mab - I-Mab and Genexine reported China NMPA clearance for Phase 2 clinical trial of TJ107/HyLeukin-7 in glioblastoma multiforme.
#MPWR -9% Monolithic Power Systems, Inc.
#MXL -9% MaxLinear, Inc. - after dropping over 6% on Thursday.
#DVAX -8% Dynavax Technologies Corporation - announced a proposed public offering of common stock.
#NNDM -6% Nano Dimension Ltd.
#HPE -5% Hewlett Packard Enterprise Co - reported weaker-than-expected Q2 results.
#GDS -5% GDS Holdings Limited - after declining over 5% on Thursday.
💥🇺🇸#DRI Stephens says Darden still a top pick, expects in-line Q1 comps
💥🇺🇸#AMED Amedisys price target raised to $260 from $250 at Oppenheimer
💥🇺🇸#ACB Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
💥🇺🇸#TLRY Tilray upgraded to Hold on cost cutting progress at Jefferies
🇺🇸#NEM #MMX #mna
Maverix Metals to acquire Gold Royalty portfolio from Newmont for $75M upfront. Newmont to sell portfolio of eleven royalties to Maverix Metals for $90M
💥🇺🇸#BXC BlueLinx price target raised to $25 from $19 at B. Riley FBR
🇺🇸#FREE Whole Earth Brands CEO Albert Manzone appointed to board of directors
💥🇺🇸#CASH Meta Financial price target raised to $27 from $25 at B. Riley FBR
🇺🇸#GTY Getty Realty CFO Danion Fielding announces intention to resign later this year
🇺🇸#VRTV Veritiv names Salvatore Abbate as CEO, succeeding Mary Laschinger
🇺🇸#DARE Dare Bioscience receives $0.9M under current grant supplement award
🇺🇸#ABIO ARCA Biopharma submits IND application for AB201 as potential COVID-19 treatment
🇺🇸#ONCT Oncternal Therapeutics presents interim TK216 data at ESMO
🇺🇸#CATB Catabasis Pharmaceuticals names Noah Clauser CFO
🇺🇸#BLFS #mna BioLife Solutions to acquire SciSafe for $30M in cash and stock
🇺🇸#EQIX #VMW Equinix expands collaboration with VMware
💥🇺🇸#SGMS Jefferies upgrades Scientific Games to Buy, raises price target to $50 from $20
🇺🇸#PTE PolarityTE receives NIH grant for a point-of-care device to treat chronic wounds
🇺🇸#ADT #mna ADT Inc. invests in Percepta Labs security technology startup
🇺🇸#BIOC Biocept: Highmark makes PCD on Target Selector liquid biopsy assay
🇺🇸#LPCN Lipocine announces completion of enrollment in the LPCN 1144 LiFT study
🇺🇸#NMRD Nemaura Medical licenses validated mobile application Healthimation
🇺🇸#NVS Siemens Healthineers announces diagnostic test collaboration with Novartis
🇺🇸#RTRX Retrophin enrolls first 280 patients in Phase 3 PROTECT trial of sparsentan
🇺🇸#XOM Exxon Mobil expands agreement with Global Thermostat
🇺🇸#IMAB I-MAB announces China NMPA clearance for Phase 1 trial of lemzoparlimab
🇺🇸#TEVA Teva launches AirDuo Digihaler, ArmonAir Digihaler inhalation powders
🇺🇸#TOL Toll Brothers reports preliminary quarter-to-date net signed contracts up 110%
💥🇺🇸#FKWL Franklin Wireless price target raised to $18 from $16 at Lake Street
🇺🇸#ESTA Establishment Labs announces publication on hybrid breast reconstruction
🇺🇸#ENPH Enphase Energy announces partnership with three solar distribution companies
🇺🇸#ATIF ATIF Holdings forms strategic collaboration with Zhuhai Boxin Technology
🇺🇸#CPST Capstone Turbine gets orders for 10 C65 microturbines, totaling 650 kilowatts,
💥🇺🇸#UPWK Upwork price target raised to $19 from $17 at BTIG
🇺🇸#SGNX Zogenix appoints Caroline Loey, Mary Stutts, Denelle Waynick to board
🇺🇸#LMNL Liminal BioSciences: FDA confirms receipt of resubmission of BLA for Ryplazim
🇺🇸#ONTX Onconova announces initiation Phase 1 trial of ON 123300 in China by partner
🇺🇸#CIT Protech Home Medical secures $20M senior credit facility
💥🇺🇸#LYV Live Nation price target raised to $56 from $43 at Morgan Stanley
🇺🇸#NNDM Nano Dimension appoints Joseph Kaplun CTO, materials
🇺🇸#REGN #SNY Regeneron, Sanofi: Libtayo increases overall survival in NSCLC
💥🇺🇸#SFIX Stitch Fix price target raised to $28 from $23 at JPMorgan
🇺🇸#TCON Tracon Pharmaceuticals highlights updated clinical data from envafolimab trial
🇺🇸#XBIT XBiotech developing human antibody combination as candidate treatment
💥🇺🇸#SBUX Starbucks price target raised to $80 from $76 at JPMorgan
🇺🇸#MRK Keytruda doubled survival rate versus chemo in certain patients NSLC
🇺🇸#HOG Harley-Davidson appoints Gina Goetter as CFO
🇺🇸#URGN UroGen Pharma price target lowered to $26 from $31 at JPMorgan
🇺🇸#WRTC Wrap Technologies says BolaWrap safely restrains suicidal subject in Florida
🇺🇸#STRS Stratus Properties announces exploration of conversion to REIT
🇺🇸#AMRS #BABA Amyris' Pipette brand selected by Alibaba for entry into China market
💥🇺🇸#EURN Euronav NV initiated with a Buy at JonesTrading
💥🇺🇸#AMED Amedisys price target raised to $260 from $250 at Oppenheimer
💥🇺🇸#ACB Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
💥🇺🇸#TLRY Tilray upgraded to Hold on cost cutting progress at Jefferies
🇺🇸#NEM #MMX #mna
Maverix Metals to acquire Gold Royalty portfolio from Newmont for $75M upfront. Newmont to sell portfolio of eleven royalties to Maverix Metals for $90M
💥🇺🇸#BXC BlueLinx price target raised to $25 from $19 at B. Riley FBR
🇺🇸#FREE Whole Earth Brands CEO Albert Manzone appointed to board of directors
💥🇺🇸#CASH Meta Financial price target raised to $27 from $25 at B. Riley FBR
🇺🇸#GTY Getty Realty CFO Danion Fielding announces intention to resign later this year
🇺🇸#VRTV Veritiv names Salvatore Abbate as CEO, succeeding Mary Laschinger
🇺🇸#DARE Dare Bioscience receives $0.9M under current grant supplement award
🇺🇸#ABIO ARCA Biopharma submits IND application for AB201 as potential COVID-19 treatment
🇺🇸#ONCT Oncternal Therapeutics presents interim TK216 data at ESMO
🇺🇸#CATB Catabasis Pharmaceuticals names Noah Clauser CFO
🇺🇸#BLFS #mna BioLife Solutions to acquire SciSafe for $30M in cash and stock
🇺🇸#EQIX #VMW Equinix expands collaboration with VMware
💥🇺🇸#SGMS Jefferies upgrades Scientific Games to Buy, raises price target to $50 from $20
🇺🇸#PTE PolarityTE receives NIH grant for a point-of-care device to treat chronic wounds
🇺🇸#ADT #mna ADT Inc. invests in Percepta Labs security technology startup
🇺🇸#BIOC Biocept: Highmark makes PCD on Target Selector liquid biopsy assay
🇺🇸#LPCN Lipocine announces completion of enrollment in the LPCN 1144 LiFT study
🇺🇸#NMRD Nemaura Medical licenses validated mobile application Healthimation
🇺🇸#NVS Siemens Healthineers announces diagnostic test collaboration with Novartis
🇺🇸#RTRX Retrophin enrolls first 280 patients in Phase 3 PROTECT trial of sparsentan
🇺🇸#XOM Exxon Mobil expands agreement with Global Thermostat
🇺🇸#IMAB I-MAB announces China NMPA clearance for Phase 1 trial of lemzoparlimab
🇺🇸#TEVA Teva launches AirDuo Digihaler, ArmonAir Digihaler inhalation powders
🇺🇸#TOL Toll Brothers reports preliminary quarter-to-date net signed contracts up 110%
💥🇺🇸#FKWL Franklin Wireless price target raised to $18 from $16 at Lake Street
🇺🇸#ESTA Establishment Labs announces publication on hybrid breast reconstruction
🇺🇸#ENPH Enphase Energy announces partnership with three solar distribution companies
🇺🇸#ATIF ATIF Holdings forms strategic collaboration with Zhuhai Boxin Technology
🇺🇸#CPST Capstone Turbine gets orders for 10 C65 microturbines, totaling 650 kilowatts,
💥🇺🇸#UPWK Upwork price target raised to $19 from $17 at BTIG
🇺🇸#SGNX Zogenix appoints Caroline Loey, Mary Stutts, Denelle Waynick to board
🇺🇸#LMNL Liminal BioSciences: FDA confirms receipt of resubmission of BLA for Ryplazim
🇺🇸#ONTX Onconova announces initiation Phase 1 trial of ON 123300 in China by partner
🇺🇸#CIT Protech Home Medical secures $20M senior credit facility
💥🇺🇸#LYV Live Nation price target raised to $56 from $43 at Morgan Stanley
🇺🇸#NNDM Nano Dimension appoints Joseph Kaplun CTO, materials
🇺🇸#REGN #SNY Regeneron, Sanofi: Libtayo increases overall survival in NSCLC
💥🇺🇸#SFIX Stitch Fix price target raised to $28 from $23 at JPMorgan
🇺🇸#TCON Tracon Pharmaceuticals highlights updated clinical data from envafolimab trial
🇺🇸#XBIT XBiotech developing human antibody combination as candidate treatment
💥🇺🇸#SBUX Starbucks price target raised to $80 from $76 at JPMorgan
🇺🇸#MRK Keytruda doubled survival rate versus chemo in certain patients NSLC
🇺🇸#HOG Harley-Davidson appoints Gina Goetter as CFO
🇺🇸#URGN UroGen Pharma price target lowered to $26 from $31 at JPMorgan
🇺🇸#WRTC Wrap Technologies says BolaWrap safely restrains suicidal subject in Florida
🇺🇸#STRS Stratus Properties announces exploration of conversion to REIT
🇺🇸#AMRS #BABA Amyris' Pipette brand selected by Alibaba for entry into China market
💥🇺🇸#EURN Euronav NV initiated with a Buy at JonesTrading